HSBC downgraded shares of Shire PLC (LON:SHP) to a hold rating in a research report sent to investors on Monday morning. The brokerage currently has GBX 5,250 ($68.53) price target on the biopharmaceutical company’s stock, down from their prior price target of GBX 5,400 ($70.49).
A number of other research analysts have also recently commented on SHP. Deutsche Bank AG restated a buy rating and set a GBX 5,600 ($73.10) price target on shares of Shire PLC in a research note on Tuesday, May 31st. Credit Suisse Group AG restated an outperform rating and set a GBX 5,000 ($65.27) price target on shares of Shire PLC in a research note on Wednesday, June 1st. JPMorgan Chase & Co. restated an overweight rating and set a GBX 5,600 ($73.10) price target on shares of Shire PLC in a research note on Wednesday, June 1st. Morgan Stanley restated an overweight rating and set a GBX 5,600 ($73.10) price target on shares of Shire PLC in a research note on Friday, June 3rd. Finally, Jefferies Group raised their price target on shares of Shire PLC from GBX 5,150 ($67.22) to GBX 6,050 ($78.97) and gave the stock a buy rating in a research note on Monday, June 6th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of Buy and an average price target of GBX 5,831.33 ($76.12).
Shire PLC (LON:SHP) opened at 5082.00 on Monday. The stock’s 50 day moving average price is GBX 4,983.69 and its 200 day moving average price is GBX 4,482.86. The company’s market capitalization is GBX 34.70 billion. Shire PLC has a 12-month low of GBX 2,707.19 and a 12-month high of GBX 5,377.00.
The company also recently declared a dividend, which will be paid on Friday, October 7th. Stockholders of record on Thursday, September 8th will be given a dividend of GBX 3.51 ($0.05) per share. The ex-dividend date is Thursday, September 8th. This represents a dividend yield of 0.07%.
In other news, insider Bohuon,Olivier purchased 134 shares of Shire PLC stock in a transaction dated Thursday, June 30th. The shares were bought at an average cost of GBX 4,463 ($58.26) per share, with a total value of £5,980.42 ($7,806.32).
About Shire PLC
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.